Associate Professor of Pharmaceutical Sciences - University of Maryland, Baltimore @PharmSciUMB. Immune Engineering, Past Chair @CRS_FG_Immuno and @AAPSNano
Baltimore, MD
Joined June 2009
- Tweets2K
- Following1.2K
- Followers1.5K
- Likes4.8K
Pinned Tweet
I am excited to share that I have been promoted to Associate Professor with Tenure at @umsop @UMBaltimore @PharmSci_UMB! I am so grateful to all of my past and present trainees, mentors, colleagues, and collaborators that have contributed immensely to the success of our lab! 👏
Ryan M. Pearson, PhD retweeted
CXCR4+ PD-L1+ neutrophils are increased in non-survived septic mice @iScience_CP
cell.com/iscience/fulltext/S…
Ryan M. Pearson, PhD retweeted
Our research is expanding beyond pregnancy. Excited to share our results by @Hilmill1113 (doi.org/10.1093/jimmun/vkae0…) investigating transplantation tolerance; and grateful to @J_Immunol, @ImmunologyAAI for streamlined review and support
Ryan M. Pearson, PhD retweeted
Innate immune memory is stimulus specific
@arjunrajlab @O_Farrell_Aoife
doi.org/10.1101/2025.01.22.6…
Ryan M. Pearson, PhD retweeted
CRS is welcoming nominations for the 2025 College of Fellows induction. We encourage members to recognize an exceptional individual who has made outstanding and sustained contributions to the field of delivery science and technology. Submit now: ow.ly/WwS850UGrr6
Extremely excited to share our latest research in Nature Communications @NatureComms! We show that inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles. rdcu.be/d68EH @PharmSci_UMB @UMBaltimore @umsop @UMmedschool
Ryan M. Pearson, PhD retweeted
Review
Tissue-resident immune cells: from defining characteristics to roles in diseases
nature.com/articles/s41392-0…
Ryan M. Pearson, PhD retweeted
Please consider registering for this Webinar from Modified Release Community by Dr. Alejandro Paredes (@paredesaj) on Jan 24 2025 from 12-1 pm EST. “Engineering Nanocrystals: Advancing Controlled and Targeted Therapies”
@AAPSComms
Register here: https:// pitt.zoom.us/meeting/registe…
Truly grateful for this opportunity from the @PhRMAfoundation to continue my work in the drug delivery space with immunemodulatory nanoparticles! Thank you to @RyanMPearson for his mentorship and to the lab for all their support! 🧪🥼 #WomenInSTEM
Ryan M. Pearson, PhD retweeted
Thrilled to share our recent work out today in @Nature on an mRNA therapeutic to treat pre-eclampsia! This work has been a true passion project from my time @pennbioeng in @MJMitchell_Lab, and I’m excited to continue important research in women’s health!
nature.com/articles/s41586-0…
Ryan M. Pearson, PhD retweeted
Should we intensify efforts to convert some of our white adipose tissue to brown fat? cell.com/cell-metabolism/abs… @Cell_Metabolism
Ryan M. Pearson, PhD retweeted
We are hiring post-doctoral Research Associates on several federally funded projects! Interested candidates please apply using the link below:
case.edu/academic-careers/re…
If you have experience, expertise and interest in:
- Vascular Biology
- Platelets and coagulation
- Nanomedicine
- Microfluidics and organ-on-chip
- Technology translation
Come join our team @CWRUBME @CaseEngineer @CWRUSOM !!
Apply here:
case.edu/academic-careers/re…
#DoDFunded
RT 🙏🏽
Ryan M. Pearson, PhD retweeted
Seize this exciting opportunity to share your research with fellow international delivery scientists! The deadline to submit abstracts is January 6, 2025. Learn more about this opportunity and submission requirements here: ow.ly/Siog50Uc7JT
Excited to share our study on microfluidics and tangential flow filtration (TFF) for scalable production of polymer NPs. Interestingly, we found purification method-dependent effects on biodistribution, protein corona, and bioactivity. RSC Pharmaceutics tinyurl.com/mwvmycfa
Ryan M. Pearson, PhD retweeted
Biggest medical discoveries of the week (🧵)
1/8
A malaria vaccine - attenuated P. falciparum arrested in the late liver stage - provided 89% protection in a trial of 9 people
This could improve the modest, short-lived protection of current vaccines
nejm.org/doi/full/10.1056/NE…
Ryan M. Pearson, PhD retweeted
New content online: Expanding applications of therapies based on GLP1 go.nature.com/4fWaDyj
Ryan M. Pearson, PhD retweeted
The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers
cell.com/cell/fulltext/S0092…
Ryan M. Pearson, PhD retweeted
Come join our team! My lab in @Rice_BIOE is hiring postdocs with expertise in immunology (tinyurl.com/3v6aumta), genome editing (tinyurl.com/48adap27), or chemistry (tinyurl.com/5n7erutf). Please apply or encourage your trainees to apply! RTs appreciated.
Making my way over to bsky. Give me a follow if you're interested in immune engineering research: @ryanmpearson.bsky.social
I'm excited to share our preprint on a novel plant-derived nanoparticle (PDNP) that sequesters pro-inflammatory cytokines and acute phase proteins in its protein corona, enhancing survival in sepsis🌿 tinyurl.com/3krmswvm
